Legal & General Group’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,741
| Closed | -$11.1K | – | 3413 |
|
|
2024
Q1 | $11.1K | Buy |
4,741
+2,000
| +73% | +$4.7K | ﹤0.01% | 3181 |
|
|
2023
Q4 | $5.17K | Hold |
2,741
| – | – | ﹤0.01% | 3322 |
|
|
2023
Q3 | $3.76K | Hold |
2,741
| – | – | ﹤0.01% | 3377 |
|
|
2023
Q2 | $6.65K | Sell |
2,741
-976
| -26% | -$2.37K | ﹤0.01% | 3361 |
|
|
2023
Q1 | $21.4K | Sell |
3,717
-4,076
| -52% | -$23.5K | ﹤0.01% | 3051 |
|
|
2022
Q4 | $69.7K | Buy |
7,793
+496
| +7% | +$4.43K | ﹤0.01% | 2890 |
|
|
2022
Q3 | $104K | Buy |
7,297
+939
| +15% | +$13.4K | ﹤0.01% | 2809 |
|
|
2022
Q2 | $93K | Buy |
6,358
+4,270
| +205% | +$62.5K | ﹤0.01% | 2875 |
|
|
2022
Q1 | $42K | Buy |
2,088
+422
| +25% | +$8.49K | ﹤0.01% | 3026 |
|
|
2021
Q4 | $29K | Hold |
1,666
| – | – | ﹤0.01% | 3156 |
|
|
2021
Q3 | $13K | Hold |
1,666
| – | – | ﹤0.01% | 3394 |
|
|
2021
Q2 | $17K | Buy |
+1,666
| New | +$17K | ﹤0.01% | 3340 |
|
|
2020
Q2 | – | Sell |
-357
| Closed | -$3K | – | 3404 |
|
|
2020
Q1 | $3K | Hold |
357
| – | – | ﹤0.01% | 3305 |
|
|
2019
Q4 | $4K | Hold |
357
| – | – | ﹤0.01% | 3345 |
|
|
2019
Q3 | $22K | Hold |
357
| – | – | ﹤0.01% | 3100 |
|
|
2019
Q2 | $26K | Buy |
357
+194
| +119% | +$14.1K | ﹤0.01% | 3098 |
|
|
2019
Q1 | $8K | Hold |
163
| – | – | ﹤0.01% | 3272 |
|
|
2018
Q4 | $10K | Hold |
163
| – | – | ﹤0.01% | 3270 |
|
|
2018
Q3 | $17K | Hold |
163
| – | – | ﹤0.01% | 3243 |
|
|
2018
Q2 | $10K | Hold |
163
| – | – | ﹤0.01% | 3296 |
|
|
2018
Q1 | $11K | Buy |
+163
| New | +$11K | ﹤0.01% | 3206 |
|